Doctor profile · Federal record

Dr. Booth Durham, MD

Dermatology Physician (CMS: Dermatology) · Sewell, NJ

  • NPI 1740392075
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 51 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
570 Egg Harbor RD Ste C1
Sewell, NJ 08080
(856) 256-8899

Credentials & registration

NPPES · NUCC
NPI registered
August 2006 — 20 yrs on file
Profile last updated
August 3, 2025
Year of graduation
1975 — 51 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
New Jersey #25MA03237000

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1740392075. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
10,245
Distinct HCPCS
10
Medicare allowed
$1,158,281
HCPCS Description Services Patients Avg allowed
J3245 Injection, tildrakizumab, 1 mg 6,400 17 $138
99213 Established patient office or other outpatient visit, 20-29 minutes 1,094 717 $98
17003 Destruction of precancer skin growth, 2-14 growths 1,079 207 $7
17000 Destruction of precancer skin growth, 1 growth 414 304 $54
11102 Biopsy of related skin growth, first growth 211 189 $100
17280 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less 148 123 $136
99212 Established patient office or other outpatient visit, 10-19 minutes 97 80 $62
96372 Injection of drug or substance under skin or into muscle 88 27 $16
17261 Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm 83 64 $142
17270 Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less 67 54 $147

In context: peer comparison

Among 2 peers in Sewell Dermatology Physician, average services per provider: 296. This provider delivers 35× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$4,605
Transactions
211
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 32 $677.67
Arcutis Biotherapeutics, INC. 15 $538.92
Janssen Biotech, INC. 5 $440.44
Ucb, INC. 15 $374.71
Lilly USA, LLC 15 $327.69
Incyte Corporation 12 $302.73
Leo Pharma INC. 28 $239.70
Regeneron Healthcare Solutions, INC. 8 $226.57
Novartis Pharmaceuticals Corporation 20 $202.96
Genzyme Corporation 6 $202.25
Galderma Laboratories, L.P. 10 $175.84
Ortho Dermatologics, A Division of Bausch Health US, LLC 16 $165.88
Dermavant Sciences, INC. 27 $165.05
Merz North America, INC. 1 $114.10
Boehringer Ingelheim Pharmaceuticals, INC. 1 $107.84

By nature of payment

Food and Beverage
$4,506
Education
$99

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
951
Patients
521
Total drug cost
$105,538
Drug Type Claims Patients Total cost
Mupirocin Generic 180 134 $1,562
Triamcinolone Acetonide Generic 172 111 $2,252
Ketoconazole Generic 107 60 $2,775
Minoxidil Generic 91 28 $926
Hydrocortisone Generic 60 37 $485
Valacyclovir (Valacyclovir Hcl) Brand 55 21 $1,348
Clobetasol Propionate Generic 42 24 $2,594
Mometasone Furoate Generic 41 30 $1,022
Doxycycline Monohydrate Generic 36 15 $1,275
Desoximetasone Generic 35 14 $2,691

Frequently asked questions

Auto-generated from federal data
What is Dr. Booth Durham's medical specialty?
Dr. Booth Durham practices Dermatology Physician in Sewell, NJ.
Where does Dr. Booth Durham practice?
Dr. Booth Durham practices at 570 Egg Harbor RD Ste C1, Sewell, NJ 08080. Office phone: 8562568899.
What is Dr. Booth Durham's NPI?
Dr. Booth Durham's National Provider Identifier (NPI) is 1740392075, issued by NPPES.
Does Dr. Booth Durham accept Medicare assignment?
Yes. Dr. Booth Durham accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Booth Durham commonly perform?
Top Medicare-reported procedures in 2023: Injection, tildrakizumab, 1 mg (HCPCS J3245); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003). Source: CMS Medicare Physician & Other Practitioners file.